Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mirum Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Mirum Pharmaceuticals

Mirum Pharmaceuticals

Public

Mirum Pharmaceuticals, Inc.: A US-based biopharmaceutical company specializing in cholestatic liver disease therapies.

HQ
Foster City, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Mirum Pharmaceuticals, Inc. is a US-based biopharmaceutical company dedicated to developing therapies for cholestatic liver diseases. The company's mission is to address the unmet needs of patients with rare liver conditions by creating transformative treatments. Mirum Pharmaceuticals focuses on providing innovative solutions that significantly improve the quality of life for patients and their families.

Mirum Pharmaceuticals has made significant strides in the field of liver disease treatment, earning recognition for its commitment to scientific innovation and patient care. The company’s therapies have shown promise in clinical trials, positioning Mirum as a leader in the biopharmaceutical industry. Their efforts have had a profound impact on the lives of those affected by cholestatic liver diseases, underscoring the company's dedication to making a remarkable difference.

Mirum Pharmaceuticals - Similar Companies

Intercept Pharmaceuticals logo

Intercept Pharmaceuticals

Mirata Pharmaceuticals logo

Mirata Pharmaceuticals

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Lumos Pharma logo

Lumos Pharma

lumos-pharma.com

Mira Oncology logo

Mira Oncology

Assertio Holdings logo

Assertio Holdings

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Marius Pharmaceuticals logo

Marius Pharmaceuticals

mariuspharma.com

Galmed Pharmaceuticals logo

Galmed Pharmaceuticals

galmedpharma.com

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Marinus Pharmaceuticals logo

Marinus Pharmaceuticals

marinuspharma.com

Enanta Pharmaceuticals logo

Enanta Pharmaceuticals

enanta.com

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Mirum Pharmaceuticals - Quick Facts

Who are Mirum Pharmaceuticals' competitors?

Companies similar to Mirum Pharmaceuticals include Intercept Pharmaceuticals, Mirata Pharmaceuticals, Catalyst Pharmaceuticals and Bayer Pharmaceuticals.

When was Mirum Pharmaceuticals founded?

Mirum Pharmaceuticals was founded in 2018.

Where is Mirum Pharmaceuticals' headquarters located?

Mirum Pharmaceuticals' headquarters is located in Foster City, CA, US.

When was Mirum Pharmaceuticals' last funding round?

Mirum Pharmaceuticals' most recent funding round was for $275M (USD) in April 2023.

How much has Mirum Pharmaceuticals raised to-date?

As of Apr 13, 2023, Mirum Pharmaceuticals has raised a total of $497M (USD).

How many employees does Mirum Pharmaceuticals have?

Mirum Pharmaceuticals has 196 employees as of Feb 6, 2024.

Mirum Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
  • Pharmaceutical
Unique IDs
  • ein: 831281555
  • secCik: 0001759425
  • ticker: MIRM
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research